DB17849InvestigationalGene Therapies
tgAAVCF is an adeno-associated virus (AAV) vector encoding the human cystic fibrosis transmembrane conductance regulator protein (CFTR) cDNA. It is being investigated for the treatment of cystic fibrosis.
What you can answer from here — as of September 25, 2025
Which companies are running trials of tgAAVCF, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account